首页> 美国卫生研究院文献>SAGE Open Medical Case Reports >Mixed large and small cell neuroendocrine carcinoma and endometrioid carcinoma of the endometrium with high microsatellite instability: A case report and literature review
【2h】

Mixed large and small cell neuroendocrine carcinoma and endometrioid carcinoma of the endometrium with high microsatellite instability: A case report and literature review

机译:混合大型和小细胞神经内分泌癌和子宫内膜的子宫内膜癌具有高微卫星不稳定性:案例报告和文献综述

代理获取
本网站仅为用户提供外文OA文献查询和代理获取服务,本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文,但由于OA文献来源多样且变更频繁,仍可能出现获取不到、文献不完整或与标题不符等情况,如果获取不到我们将提供退款服务。请知悉。

摘要

A 65-year-old, gravida 3, para 2 Japanese woman was referred to our hospital for symptomatic thickening of the endometrial lining. Endocervical and endometrial cytology revealed an adenocarcinoma. The endometrial biopsy specimen was mixed, with a glandular part diagnosed as endometrioid carcinoma and a solid part diagnosed as high-grade mixed large and small cell neuroendocrine carcinoma (L/SCNEC). She underwent extra-fascial hysterectomy with bilateral salpingo-oophorectomy, complete pelvic and para-aortic lymphadenectomy, and omentectomy (FIGO IIIB, pT3b pN0 M0). She currently has no deleterious germline mutation, but high tumor mutation burden and high microsatellite instability (MSI) were identified. She underwent six cycles of platinum-based frontline chemotherapy and achieved complete remission. Immune checkpoint blockade therapy is a promising second-line therapy for MSI-high solid tumors. However, the MSI or mismatch repair (MMR) status of endometrial L/SCNEC remains unclear in the literature. Universal screening for MSI/MMR status is needed, particularly for a rare and aggressive disease.
机译:一位65岁的雷达3,第2段日本女子被称为食子宫内膜衬里的症状增厚。内炎和子宫内膜细胞学显示出腺癌。将子宫内膜活检标本混合,腺体部分被诊断为子宫内甲状腺癌和固体部分被诊断为高级混合大小细胞神经内分泌癌(L / SCNEC)。她接受了与双侧Salpingo-Oophorectomy,完整的盆腔和帕拉主动脉淋巴结切除术,易切除术(FIGO IIIB,PT3B PN0 M0)的漂浮肌卵囊切除术。她目前没有任何有害的种系突变,但鉴定了高肿瘤突变负担和高微卫星不稳定性(MSI)。她接受了六周期的铂金前化疗,并取得了完全缓解。免疫检查点阻断治疗是MSI高固体肿瘤的有希望的二线治疗。然而,文献中,子宫内膜L / SCNEC的MSI或不匹配修复(MMR)状态仍不清楚。需要满足MSI / MMR状态的通用筛选,特别是对于罕见和侵略性的疾病。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
代理获取

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号